STAMFORD, Conn. — Curaleaf Holdings Inc., a leading international provider of consumer cannabis products, acquired the equity stake in Curaleaf International Holdings Limited previously held by a single strategic institutional investor. The transaction brings the Company’s stake in its European holding company to 100%.
Financial details of the transaction were not disclosed.
The transaction represents the completion of a Put/Call Option that was agreed with the strategic investor at the time of its participation in Curaleaf’s move into Europe in 2021. Following the pricing mechanism incorporated in the Put/Call Option, the investor elected to receive the purchase entirely in Curaleaf Subordinate Voting Shares.
The acquisition strengthens the Company’s control over its European operations, enabling enhanced strategic alignment across international markets. The request of the strategic investor to settle the transaction for Company shares underscores the investor’s long-term support and confidence in the future of Curaleaf.
The issuance of the Subordinate Voting Shares in connection with the transaction was conditionally approved by the Toronto Stock Exchange on June 25, subject to fulfilling customary listing conditions. The transaction was completed on July 2.
Boris Jordan, Executive Chairman of Curaleaf Holdings Inc., commented, “This consolidation of ownership of our European holding company enables us to streamline decision-making, strengthen alignment across regions, and accelerate our strategic initiatives in Europe with greater autonomy. This development marks another important milestone in Curaleaf’s continued commitment to international expansion and long-term value creation for shareholders. We thank our partners for their long-standing support and belief in Curaleaf’s future.”
About Curaleaf Holdings
Curaleaf Holdings Inc. (TSX: CURA) (OTCQX: CURLF) is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. The Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, provide service, product selection, and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cultivation, extraction, and production.
About Curaleaf International
Curaleaf International’s network includes a clinic, pharmacy, and laboratory in the UK; cultivation and EU-GMP processing facilities in Portugal; an EU-GMP processing, quality assurance and research site in Spain; Four20 Pharma wholesaler and distributor in Germany; a Polish wholesaler and clinic; and the EU-GMP producer Northern Green Canada.
